Gentherm raises 2026 outlook while targeting $3.5B+ revenue by 2030 through Modine combination (NASDAQ:THRM)July 23, 2026
Share Facebook Twitter LinkedIn Pinterest Email Notable healthcare headlines for the week: UnitedHealth, Bristol Myers Squibb, and Hims & Hers in focus
Gentherm raises 2026 outlook while targeting $3.5B+ revenue by 2030 through Modine combination (NASDAQ:THRM)July 23, 2026